‌

A Post-Marketing Observational Study of VYXEOS™

Overview Structured Data Issues Contributors

clinicaltrials.gov/study/NCT03526926

Is a

0

Clinical Study attributes

NCT Number

Trial Recruitment Size

520

Trial Sponsor

Jazz Pharmaceuticals

0

Clinical Trial Start Date

October 23, 2018

0

Primary Completion Date

October 26, 2019

0

Study Completion Date

June 12, 2020

0

Clinical Trial Study Type

Observational0

Intervention Type

Drug0

Intervention Name

CPX-3510

Observational Clinical Trial Type

Cohort0

Observational Study Perspective

Prospective0

Participating Facility

Washington University School of Medicine

0

Wake Forest University School of Medicine

0

University of Kansas Medical Center

0

University of Maryland

0

Official Name

A Post-Marketing Observational Study of VYXEOS™ to Assess the Incidence of Infusion-Related Reactions in Adult Patients0

Last Updated

August 5, 2020

0

Study summary

The purpose of this observational study is to provide data on the incidence and severity of infusion-related reactions during and immediately following each infusion of VYXEOS during the first induction.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like A Post-Marketing Observational Study of VYXEOS™

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.